InvestorsHub Logo
Followers 52
Posts 2237
Boards Moderated 0
Alias Born 07/06/2011

Re: MRatt post# 12626

Tuesday, 10/21/2014 3:16:22 PM

Tuesday, October 21, 2014 3:16:22 PM

Post# of 40503
Great news about funding for DNA based mAB production against infectious diseases, similar to what INO has already done with Chikungunya virus:

http://ir.inovio.com/news/news-releases/news-releases-details/2014/Inovio-Pharmaceuticals-Breakthrough-DNA-Based-Monoclonal-Antibody-Therapy-Completely-Protects-Animals-From-Lethal-Viral-Challenge/default.aspx

I always wondered if ZMapp antibodies work against Ebola but they are having production issues, why not just give INO's DNA for the anti-Ebola antibodies, and have the patients make the antibodies themselves (instead of producing them via genetic engineering in tobacco plants outside the body)?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News